OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers in rosacea: A systematic review
Ryan S.Q. Geng, Adrienn N. Bourkas, R. Gary Sibbald, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 6, pp. 1048-1057
Open Access | Times Cited: 13

Showing 13 citing articles:

The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway
Rui Sun, Huiping Fan, Jiayun Liu, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 8
Closed Access | Times Cited: 5

Proteomic Profiling and Clinical Insights: The Role of MMP9 in Differentiating Psoriasis Vulgaris from Generalized Pustular Psoriasis
Ting Gong, Jiawen Chen, Zhixun Xiao, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3795-3805
Open Access

Causal relationship and potential pathogenic mechanisms between rosacea with pharyngeal and laryngeal cancer
Zexin Zhu, Xiaoxue Wang
Brazilian Journal of Otorhinolaryngology (2025) Vol. 91, Iss. 4, pp. 101636-101636
Closed Access

The Use of Plants That Seal Blood Vessels in Preparations Applied Topically to the Skin: A Review
Barbara Hanna Roman, Anna Muzykiewicz-Szymańska, Katarzyna Florkowska, et al.
Molecules (2025) Vol. 30, Iss. 9, pp. 1973-1973
Open Access

Drug repositioning for rosacea disease: Biological TARGET identification, molecular docking, pharmacophore mapping, and molecular dynamics analysis
Gustavo Adolfo Barraza, Ana Carla Castro-Guijarro, Valentina de la Fuente Hoffmann, et al.
Computers in Biology and Medicine (2024) Vol. 181, pp. 108988-108988
Closed Access | Times Cited: 3

Biomarkers for rosacea?
Shirley P. Parraga, Steven R. Feldman
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 6, pp. 993-994
Open Access | Times Cited: 1

Unveiling the Mechanism of Liangxue Siwu Decoction in Treating Rosacea Through Network Pharmacology and in-vitro Experimental Validation
Yun Zhong, Yufei Zhao, Xin Meng, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5685-5699
Open Access | Times Cited: 1

Serum Biomarkers IL-6 and HIF-1α in Rosacea: Assessing Their Significance in Disease Pathogenesis and Telangiectasia Formation
Gamze Tas Aygar, Bengü Çevirgen Cemil, Fevzi Nuri Aydın, et al.
Dermatology Practical & Conceptual (2024) Vol. 14, Iss. 4, pp. e2024267-e2024267
Open Access | Times Cited: 1

ROSACEA: TRIGGER, TOPICAL THERAPIES AND MAINTENANCE REGIMES
Maria Elisa Sobral Vila Nova de Carvalho Vieira, Lívia Cunha dos Santos, Izabella Alves Pizani, et al.
Revista Ibero-Americana de Humanidades, Ciências e Educação (2024) Vol. 10, Iss. 6, pp. 1973-0984
Open Access

Important Roles of Interleukin-36, Interleukin-37, and Interleukin-38 Cytokines in the Pathogenesis of Rosacea
Alper Ekinci, Sevilay Kılıç, Nesrin Demir, et al.
Indian Journal of Dermatology (2024) Vol. 69, Iss. 3, pp. 232-237
Open Access

The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway
Rui Sun, Huiping Fan, Jiayun Liu, et al.
Research Square (Research Square) (2024)
Closed Access

RESEARCH ROUNDUP
Claudia Mcgloin
Journal of Aesthetic Nursing (2024) Vol. 13, Iss. 5, pp. 231-232
Closed Access

Efficacy of Treatments in Reducing Facial Erythema in Rosacea: A Systematic Review
Nicholas Hua, Jennifer Chen, Ryan S.Q. Geng, et al.
Journal of Cutaneous Medicine and Surgery (2024)
Open Access

Page 1

Scroll to top